ESMO 2019 ... | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

  • LIMITED OFFER

    30% off entry-level Bronze Patron packages (retails for $250 - reduced to $175)
    includes 2 yrs of Premium Plus service & locks in 30% discount for any future Patron upgrades

    Only 35 spots available (first come, first served)

    BONUS: Purchase your spot over the next 24 hrs & get an extra year of Premium Plus service absolutely free! 

    CLICK HERE to become a Bronze Patron now 


IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1522 of 1614  at  9/10/2019 10:01:03 AM  by

auh2oman


ESMO 2019 ...

The poster to be presented. The publication date is  Monday, 23 September 2019:
 

1195P - Safety, efficacy, and immune effects of intratumoral tilsotolimod in patients with refractory solid tumors: updated results from ILLUMINATE-101 (ID 2882)

Presentation Number
1195P
Lecture Time
12:00 - 12:00
Speakers
  • Hani Babiker (Tucson, United States of America)
 
 
Dr. Babiker,MD was the contact at the University of Arizona Cancer Center
 
 
 
 
 
 https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/session/calendar?q=Tilsotolimod
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 227
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...